• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嵌合抗原受体T细胞(CAR-T)相关神经毒性患者中与语言功能障碍相关的脑电图表现

Language dysfunction-associated EEG findings in patients with CAR-T related neurotoxicity.

作者信息

Sokolov Elisaveta, Karschnia Philipp, Benjamin Reuben, Hadden Robert D M, Elwes Robert C D, Drummond Lee, Amin Devyani, Paiva Vitor, Pennisi Alex, Herlopian Aline, Frigault Matthew, Sanderson Robin, Inam Shafqat, Cole Andrew J, Dietrich Jorg

机构信息

Department of Neurology, Harvard University, Cambridge, Massachusetts, USA.

Department of Neurosurgery, Ludwig Maximilians University Munich, Munchen, Bayern, Germany.

出版信息

BMJ Neurol Open. 2020 Jun 18;2(1):e000054. doi: 10.1136/bmjno-2020-000054. eCollection 2020.

DOI:10.1136/bmjno-2020-000054
PMID:33681787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7871716/
Abstract

UNLABELLED

Chimeric antigen receptor-modified T cells (CAR-T) have emerged as a promising immunotherapeutic approach in relapsed/refractory haematolgical malignancies. Broader application is limited by unique toxicities, notably, neurotoxicity (NTX). Language dysfunction is among the most frequent symptoms of NTX, the underlying mechanisms of which remain to be elucidated. Electroencephalogram (EEG) is an important tool to monitor for NTX and may provide insights into language dysfunction.

AIM

We aimed to characterise language dysfunction and define electroencephalographic signatures after CAR-T cell therapy.

METHODS

We reviewed the clinical presentation and EEG findings of 20 adult patients presenting with language dysfunction after CAR-T cell infusion. The cohort included a subset of patients treated with investigational CD19-directed CAR-T cells for non-Hodgkin's lymphoma (n=17), acute lymphoblastic leukaemia (n=1), follicular lymphoma (n=1) and chronic lymphocytic leukaemia (n=1).

RESULTS

Language dysfunction presented within 14 days of CAR-T cell infusion in 16 (84%) patients. Ten (50%) patients had mild word-finding difficulties and 10 (50%) had marked dysphasia with profound word-finding difficulties; the latter were all associated with generalised rhythmic delta activity or generalised periodic discharges on EEG.

CONCLUSIONS

Language dysfunction after CAR-T cell therapy is associated with generalised EEG abnormalities.

摘要

未标注

嵌合抗原受体修饰的T细胞(CAR-T)已成为复发/难治性血液系统恶性肿瘤中一种有前景的免疫治疗方法。更广泛的应用受到独特毒性的限制,尤其是神经毒性(NTX)。语言功能障碍是NTX最常见的症状之一,其潜在机制仍有待阐明。脑电图(EEG)是监测NTX的重要工具,可能有助于深入了解语言功能障碍。

目的

我们旨在描述CAR-T细胞治疗后的语言功能障碍特征并确定脑电图特征。

方法

我们回顾了20例CAR-T细胞输注后出现语言功能障碍的成年患者的临床表现和脑电图结果。该队列包括一部分接受研究性CD19导向的CAR-T细胞治疗非霍奇金淋巴瘤(n = 17)、急性淋巴细胞白血病(n = 1)、滤泡性淋巴瘤(n = 1)和慢性淋巴细胞白血病(n = 1)的患者。

结果

16例(84%)患者在CAR-T细胞输注后14天内出现语言功能障碍。10例(50%)患者有轻度找词困难,10例(50%)有明显的失语症且找词困难严重;后者均与脑电图上的广泛性节律性δ活动或广泛性周期性放电有关。

结论

CAR-T细胞治疗后的语言功能障碍与广泛性脑电图异常有关。

相似文献

1
Language dysfunction-associated EEG findings in patients with CAR-T related neurotoxicity.嵌合抗原受体T细胞(CAR-T)相关神经毒性患者中与语言功能障碍相关的脑电图表现
BMJ Neurol Open. 2020 Jun 18;2(1):e000054. doi: 10.1136/bmjno-2020-000054. eCollection 2020.
2
Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector: a unicentre phase I/II clinical trial protocol.采用 RV-SFG.CD19.CD28.4-1BBzeta 逆转录病毒载体转导的 T 淋巴细胞治疗复发或难治性 CD19+淋巴组织疾病患者的单中心 I/II 期临床试验方案。
BMJ Open. 2019 May 19;9(5):e026644. doi: 10.1136/bmjopen-2018-026644.
3
Anti-CD19 chimeric antigen receptor T-cell therapy in acute lymphocytic leukaemia: a systematic review and meta-analysis.抗CD19嵌合抗原受体T细胞疗法治疗急性淋巴细胞白血病:一项系统评价和荟萃分析。
Lancet Haematol. 2020 Nov;7(11):e816-e826. doi: 10.1016/S2352-3026(20)30277-5.
4
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.用于治疗儿童和青年急性淋巴细胞白血病的表达CD19嵌合抗原受体的T细胞:一项1期剂量递增试验
Lancet. 2015 Feb 7;385(9967):517-528. doi: 10.1016/S0140-6736(14)61403-3. Epub 2014 Oct 13.
5
EEG findings in CAR T-cell-associated neurotoxicity: Clinical and radiological correlations.CAR T 细胞相关性神经毒性的脑电图表现:临床与影像学相关性。
Neuro Oncol. 2022 Feb 1;24(2):313-325. doi: 10.1093/neuonc/noab174.
6
Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.利妥昔单抗:用于非霍奇金淋巴瘤和慢性淋巴细胞白血病的综述
Drugs. 2003;63(8):803-43. doi: 10.2165/00003495-200363080-00005.
7
Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells.嵌合抗原受体 T 细胞过继免疫治疗后的神经毒性的临床表现、治疗和生物标志物。
Blood. 2019 May 16;133(20):2212-2221. doi: 10.1182/blood-2018-12-893396. Epub 2019 Feb 26.
8
Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells.使用特定比例的CD8+和CD4+ CD19特异性嵌合抗原受体修饰的T细胞对非霍奇金淋巴瘤进行免疫治疗。
Sci Transl Med. 2016 Sep 7;8(355):355ra116. doi: 10.1126/scitranslmed.aaf8621.
9
CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: Transforming the Treatment of Relapsed and Refractory Disease.嵌合抗原受体T细胞疗法治疗急性淋巴细胞白血病:改变复发难治性疾病的治疗方式
Curr Hematol Malig Rep. 2018 Oct;13(5):396-406. doi: 10.1007/s11899-018-0470-x.
10
Neurological management and work-up of neurotoxicity associated with CAR T cell therapy.嵌合抗原受体T细胞疗法相关神经毒性的神经学管理及检查
Neurol Res Pract. 2022 Jan 10;4(1):1. doi: 10.1186/s42466-021-00166-5.

引用本文的文献

1
EEG as a predictive biomarker of neurotoxicity in anti-CD19 CAR T-cell therapy.脑电图作为抗CD19嵌合抗原受体T细胞疗法中神经毒性的预测生物标志物。
J Neurol. 2025 Apr 25;272(5):360. doi: 10.1007/s00415-025-13102-3.
2
PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasis.程序性死亡受体1(PD-1)阻断疗法并不能提高靶向上皮细胞黏附分子(EpCAM)的嵌合抗原受体(CAR)T细胞治疗肺癌脑转移的疗效。
Cancer Immunol Immunother. 2024 Oct 3;73(12):255. doi: 10.1007/s00262-024-03837-9.
3
Automated detection of immune effector cell-associated neurotoxicity syndrome via quantitative EEG.

本文引用的文献

1
Chimeric Antigen Receptor T-Cell Therapy: What the Neuroradiologist Needs to Know.嵌合抗原受体 T 细胞疗法:神经放射科医师需要了解的内容。
AJNR Am J Neuroradiol. 2019 May;40(5):766-768. doi: 10.3174/ajnr.A6042. Epub 2019 May 2.
2
Neurological toxicities associated with chimeric antigen receptor T-cell therapy.嵌合抗原受体 T 细胞疗法相关的神经毒性。
Brain. 2019 May 1;142(5):1334-1348. doi: 10.1093/brain/awz053.
3
Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells.
通过定量脑电图自动检测免疫效应细胞相关神经毒性综合征。
Ann Clin Transl Neurol. 2023 Oct;10(10):1776-1789. doi: 10.1002/acn3.51866. Epub 2023 Aug 6.
4
CAR-T cells neurotoxicity from consolidated practice in hematological malignancies to fledgling experience in CNS tumors: fill the gap.嵌合抗原受体T细胞(CAR-T)细胞的神经毒性:从血液系统恶性肿瘤的成熟实践到中枢神经系统肿瘤的初步经验,填补差距。
Front Oncol. 2023 Jun 16;13:1206983. doi: 10.3389/fonc.2023.1206983. eCollection 2023.
5
Frontal Intermittent Rhythmic Delta Activity Is a Useful Diagnostic Tool of Neurotoxicity After CAR T-Cell Infusion.前额间歇性节律性德尔塔活动是 CAR T 细胞输注后神经毒性的有用诊断工具。
Neurol Neuroimmunol Neuroinflamm. 2023 Apr 14;10(4). doi: 10.1212/NXI.0000000000200111. Print 2023 Jul.
6
dynamics and anti-tumor effects of EpCAM-directed CAR T-cells against brain metastases from lung cancer.针对肺癌脑转移的 EpCAM 导向 CAR T 细胞的动力学和抗肿瘤作用。
Oncoimmunology. 2023 Jan 13;12(1):2163781. doi: 10.1080/2162402X.2022.2163781. eCollection 2023.
7
Continuous EEG monitoring detects nonconvulsive seizure and Ictal-Interictal Continuum abnormalities in moderate to severe ICANS following systemic CAR-T therapy.持续脑电图监测可检测全身CAR-T治疗后中度至重度免疫效应细胞相关神经毒性综合征(ICANS)中的非惊厥性癫痫发作和发作期-发作间期连续异常。
Neurohospitalist. 2023 Jan;13(1):53-60. doi: 10.1177/19418744221128852. Epub 2022 Oct 12.
8
EEG-based grading of immune effector cell-associated neurotoxicity syndrome.基于脑电图的免疫效应细胞相关神经毒性综合征分级。
Sci Rep. 2022 Nov 21;12(1):20011. doi: 10.1038/s41598-022-24010-1.
9
GFAP and NfL increase during neurotoxicity from high baseline levels in pediatric CD19-CAR T-cell patients.神经毒性时 GFAP 和 NfL 从儿科 CD19-CAR T 细胞患者的高基线水平增加。
Blood Adv. 2023 Mar 28;7(6):1001-1010. doi: 10.1182/bloodadvances.2022008119.
10
Site-Specific Considerations on Engineered T Cells for Malignant Gliomas.针对恶性胶质瘤的工程化T细胞的位点特异性考量
Biomedicines. 2022 Jul 19;10(7):1738. doi: 10.3390/biomedicines10071738.
嵌合抗原受体 T 细胞过继免疫治疗后的神经毒性的临床表现、治疗和生物标志物。
Blood. 2019 May 16;133(20):2212-2221. doi: 10.1182/blood-2018-12-893396. Epub 2019 Feb 26.
4
Population of the ictal-interictal zone: The significance of periodic and rhythmic activity.发作期-发作间期区域的细胞群:周期性和节律性活动的意义
Clin Neurophysiol Pract. 2017 May 26;2:107-118. doi: 10.1016/j.cnp.2017.05.001. eCollection 2017.
5
EEG findings in CAR T-cell therapy-related encephalopathy.嵌合抗原受体T细胞疗法相关脑病的脑电图检查结果
Neurology. 2018 Jul 31;91(5):227-229. doi: 10.1212/WNL.0000000000005910. Epub 2018 Jun 29.
6
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.阿基仑赛注射液嵌合抗原受体T细胞疗法治疗难治性大B细胞淋巴瘤
N Engl J Med. 2017 Dec 28;377(26):2531-2544. doi: 10.1056/NEJMoa1707447. Epub 2017 Dec 10.
7
Chimeric antigen receptor T-cell therapies for lymphoma.嵌合抗原受体 T 细胞疗法治疗淋巴瘤。
Nat Rev Clin Oncol. 2018 Jan;15(1):31-46. doi: 10.1038/nrclinonc.2017.128. Epub 2017 Aug 31.
8
New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management.新药,新毒性:癌症现代靶向治疗和免疫治疗的严重副作用及其管理
Crit Care. 2017 Apr 14;21(1):89. doi: 10.1186/s13054-017-1678-1.
9
Association of Periodic and Rhythmic Electroencephalographic Patterns With Seizures in Critically Ill Patients.周期性和节律性脑电图模式与危重症患者癫痫发作的关联。
JAMA Neurol. 2017 Feb 1;74(2):181-188. doi: 10.1001/jamaneurol.2016.4990.
10
Chimeric Antigen Receptor T-Cell Therapy for the Community Oncologist.社区肿瘤学家的嵌合抗原受体T细胞疗法
Oncologist. 2016 May;21(5):608-17. doi: 10.1634/theoncologist.2015-0421. Epub 2016 Mar 23.